Zurich Cantonal Bank
SGMO

Zurich Cantonal Bank’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Zurich Cantonal Bank’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-436
Closed -$294 – 3369
2025
Q3 		$294 Hold
436
– – ﹤0.01% 2535
2025
Q2 		$236 Hold
436
– – ﹤0.01% 2550
2025
Q1 		$286 Hold
436
– – ﹤0.01% 2618
2024
Q4 		$445 Sell
436
-5,680
-93% -$10.4K ﹤0.01% 2632
2024
Q3 		$5.3K Sell
6,116
-2,276
-27% -$1.67K ﹤0.01% 2629
2024
Q2 		$3.01K Sell
8,392
-1,440
-15% -$778 ﹤0.01% 2628
2024
Q1 		$6.59K Sell
9,832
-305
-3% -$221 ﹤0.01% 2657
2023
Q4 		$5.51K Sell
10,137
-817
-7% -$377 ﹤0.01% 2681
2023
Q3 		$6.57K Sell
10,954
-917
-8% -$982 ﹤0.01% 2751
2023
Q2 		$15.4K Sell
11,871
-19,799
-63% -$27.1K ﹤0.01% 2733
2023
Q1 		$55.7K Hold
31,670
– – ﹤0.01% 2561
2022
Q4 		$99.4K Buy
31,670
+6,029
+24% +$23.4K ﹤0.01% 2274
2022
Q3 		$126K Sell
25,641
-233
-0.9% -$1.2K ﹤0.01% 2046
2022
Q2 		$107K Sell
25,874
-1,367
-5% -$5.91K ﹤0.01% 2184
2022
Q1 		$158K Sell
27,241
-3,568
-12% -$21.2K ﹤0.01% 2042
2021
Q4 		$231K Sell
30,809
-596
-2% -$5.18K ﹤0.01% 1971
2021
Q3 		$283K Buy
31,405
+20
+0.1% +$198 ﹤0.01% 1681
2021
Q2 		$376K Buy
31,385
+899
+3% +$10.2K ﹤0.01% 1391
2021
Q1 		$382K Buy
30,486
+14,075
+86% +$190K ﹤0.01% 1391
2020
Q4 		$256K Hold
16,411
– – ﹤0.01% 1686
2020
Q3 		$155K Hold
16,411
– – ﹤0.01% 1774
2020
Q2 		$147K Buy
16,411
+2,934
+22% +$27.2K ﹤0.01% 1735
2020
Q1 		$86K Buy
13,477
+6,590
+96% +$48.9K ﹤0.01% 1691
2019
Q4 		$58K Hold
6,887
– – ﹤0.01% 2062
2019
Q3 		$62K Hold
6,887
– – ﹤0.01% 1881
2019
Q2 		$74K Buy
6,887
+269
+4% +$2.86K ﹤0.01% 1805
2019
Q1 		$63K Sell
6,618
-169
-2% -$1.73K ﹤0.01% 1866
2018
Q4 		$78K Buy
6,787
+1,552
+30% +$19.3K ﹤0.01% 1753
2018
Q3 		$89K Buy
5,235
+524
+11% +$7.96K ﹤0.01% 1783
2018
Q2 		$67K Hold
4,711
– – ﹤0.01% 1920
2018
Q1 		$90K Hold
4,711
– – ﹤0.01% 1655
2017
Q4 		$77K Buy
4,711
+2,364
+101% +$35.2K ﹤0.01% 1749
2017
Q3 		$35K Hold
2,347
– – ﹤0.01% 2021
2017
Q2 		$21K Hold
2,347
– – ﹤0.01% 2241
2017
Q1 		$12K Hold
2,347
– – ﹤0.01% 2446
2016
Q4 		$7K Hold
2,347
– – ﹤0.01% 2503
2016
Q3 		$11K Hold
2,347
– – ﹤0.01% 2396
2016
Q2 		$14K Hold
2,347
– – ﹤0.01% 2258
2016
Q1 		$14K Hold
2,347
– – ﹤0.01% 2243
2015
Q4 		$21K Buy
2,347
+1,459
+164% +$11.2K ﹤0.01% 2037
2015
Q3 		$5K Buy
888
+567
+177% +$4.67K ﹤0.01% 2398
2015
Q2 		$4K Hold
321
– – ﹤0.01% 2072
2015
Q1 		$5K Buy
+321
New +$4.97K ﹤0.01% 1923

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Zurich Cantonal Bank's SGMO Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2025, closing a stake of 436 shares — an estimated $294 sold.

Zurich Cantonal Bank first reported a position in SGMO in Q1 2015 and held it in 43 quarters. The position peaked at $382K in Q1 2021. 105 funds tracked by Wall St. Rank hold SGMO as of Q4 2025.

  • Zurich Cantonal Bank reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 436 SANGAMO THERAPEUTICS INC shares in Q4 2025, an estimated $294.
  • Zurich Cantonal Bank first reported a position in SANGAMO THERAPEUTICS INC in Q1 2015 and held it in 43 quarters.
  • Zurich Cantonal Bank's SANGAMO THERAPEUTICS INC position peaked at $382K in Q1 2021.
  • 105 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.